About Avecho
Avecho is a company based in Notting Hill (Australia) founded in 1992.. Avecho offers products and services including TPM Technology and CBD Soft-Gel Capsule. Avecho operates in a competitive market with competitors including Zoetis, Ceva, Ensysce, Arecor and Oxular, among others.
- Headquarter Notting Hill, Australia
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Avecho Biotechnology Limited
-
Annual Revenue
$699.95 K (USD)139.19as on Dec 31, 2024
-
Net Profit
$-1.93 M (USD)9.15as on Dec 31, 2024
-
EBITDA
$-2.98 M (USD)-9.14as on Dec 31, 2024
-
Latest Funding Round
$18.12 M (USD), Post-IPO
Jul 11, 2014
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Avecho
Avecho is a publicly listed company on the ASX with ticker symbol AVE in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Avecho
Avecho offers a comprehensive portfolio of products and services, including TPM Technology and CBD Soft-Gel Capsule. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enhances delivery and effectiveness of medicines for various applications.
Treats insomnia through TPM-enhanced formulation in clinical trials.
Funding Insights of Avecho
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $18.1M
-
First Round
First Round
(11 Jul 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2014 | Amount | Post-IPO - Avecho | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Avecho
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Avecho
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avecho Comparisons
Competitors of Avecho
Avecho operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, Ensysce, Arecor and Oxular, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| domain | founded_year | HQ Location |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
|
| domain | founded_year | HQ Location |
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
|
|
| domain | founded_year | HQ Location |
Drug delivery platforms and therapeutics for ophthalmology are developed.
|
|
| domain | founded_year | HQ Location |
Erythrocyte encapsulation systems for drug delivery are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Avecho
Frequently Asked Questions about Avecho
When was Avecho founded?
Avecho was founded in 1992 and raised its 1st funding round 22 years after it was founded.
Where is Avecho located?
Avecho is headquartered in Notting Hill, Australia. It is registered at Notting Hill, Victoria, Australia.
Who is the current CEO of Avecho?
Paul Gavin is the current CEO of Avecho.
What is the annual revenue of Avecho?
Annual revenue of Avecho is $699.95K as on Dec 31, 2024.
What does Avecho do?
Avecho was founded in 1992 in Notting Hill, Australia, within the biotechnology sector focused on pharmaceutical delivery. A proprietary system known as Tocopheryl Phosphate Mixture (TPM), derived from vitamin E, is utilized to improve drug solubility and absorption through oral, dermal, and transdermal methods. Formulations incorporating TPM are being developed for low-solubility drugs targeted at human applications, with emphasis on safety for both human and animal health.
What products or services does Avecho offer?
Avecho offers TPM Technology and CBD Soft-Gel Capsule.
Is Avecho publicly traded?
Yes, Avecho is publicly traded on ASX under the ticker symbol AVE.
What is Avecho's ticker symbol?
The ticker symbol of Avecho is AVE on ASX.